Stefoni S, Vangelista A, Nanni Costa A, Bonomini V
Clin Nephrol. 1981 Dec;16(6):300-6.
Thoracic duct drainage has so far been employed in clinical nephrology mainly in renal transplantation and in immunologically mediated glomerulonephritis. The effectiveness of duct drainage in producing immunosuppression has been widely demonstrated, and several authors have used long-term, and others short-term drainage. 12 patients suffering from drug resistant immunologically mediated glomerulonephritis were treated with short-term (mean 10 days) thoracic duct drainage. In order to define the time, type and evolution of changes in immunological status, humoral and cellular immunity were studied daily in all patients. Marked changes (mainly in the number of lymphocytes drained and in their nucleic acid content and E-rosette forming capacity) take place in the first (4-5) days of drainage. These findings, together with positive clinical and laboratory results obtained in our patients, suggest that satisfactory immunosuppression may be achieved by short-term drainage, which is simpler and safer than long-term drainage. The procedure might thus be extended to a wider number of immunological diseases where drug therapy fails to take effect.
迄今为止,胸导管引流在临床肾脏病学中主要应用于肾移植和免疫介导性肾小球肾炎。导管引流产生免疫抑制的有效性已得到广泛证实,一些作者采用长期引流,另一些则采用短期引流。12例耐药性免疫介导性肾小球肾炎患者接受了短期(平均10天)胸导管引流治疗。为了确定免疫状态变化的时间、类型和演变,对所有患者每天进行体液免疫和细胞免疫研究。在引流的头(4 - 5)天会发生显著变化(主要是引流淋巴细胞的数量、其核酸含量和E玫瑰花结形成能力)。这些发现,连同我们患者获得的阳性临床和实验室结果表明,短期引流可能实现满意的免疫抑制,这比长期引流更简单、更安全。因此,该方法可能会扩展到更多药物治疗无效的免疫性疾病。